Monday, November 3, 2025 11/3/2025

Small translated ORFs in the 3'UTR enhance translation in vertebrates

Award Number: R01GM136849
ORGANIZATION: NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 12/01/2020
PERIOD OF PERFORMANCE END DATE: 05/31/2026

Group Awards By:

View Award Description

Small translated ORFs in the 3'UTR enhance translation in vertebrates - Project Summary The prevailing doctrine that messenger RNAs (mRNAs) in higher organisms encode for a single protein has undergone a dramatic revision in recent years. Ribosome and proteomic profiling have revealed a large number of small translated open reading frames (ORF) within previously described “untranslated regions” (UTRs) and long non-coding RNAs. Indeed, some of the peptides derived from small ORFs have been implicated in various fundamental processes (e.g., development). Translation of small ORFs in the 5’UTR, known as upstream-ORFs (uORFs), has been shown to have a profound regulatory effect on gene regulation, independent of the encoded peptide. Further, translation of uORFs vary under pathologic conditions such as cancer, and mutations affecting uORFs are associated with various human diseases. We and others have also indicated the existence of translated small ORFs in the 3’UTR known as downstream open reading frames (dORFs) in human cells and zebrafish embryos. However, contrary to uORFs, there has been no systematic study of dORF functions, and their relationship to human health and disease remains untested. Further, given their location in the 3’UTR, the molecular mechanism by which dORFs engage the translational machinery remain completely unknown. Our long-term goal is to understand how post-transcriptional regulation (mRNA half-life and translation) shapes gene expression in vertebrates, and its impact on human disease. The central hypothesis of this application is that translation of dORFs regulates gene expression. Our preliminary data strongly indicate that, contrary to uORFs, dORFs strongly enhance translation of the canonical ORF and emerge as an uncharacterized and potent regulatory mechanism across vertebrates. The objectives are to: 1) Identify factors involved in enhancing translation of the main ORF. 2) Dissect the regulatory information driving dORF translation, and 3) Characterize the biological impacts of dORF-mediated regulation. The rationale for the proposed research is to gain a mechanistic understanding of dORF-mediated regulation in order to assess the possible biological importance of dORF dysregulation under stress or disease conditions. This proposal is conceptually innovative as it is based on the exploration of a novel, yet widespread and potent translation regulatory mechanism conserved across vertebrates. Technically, this proposal will combine genomic profiles (RNA-seq, Ribosome profiling); reporter (cytometry); biochemistry tools: RNA pulldowns follow by proteomics, CRISPR-Cas-9 and - 12a (to edit) and our novel Cas13d tool (knock-down in embryos); combining human cell and zebrafish embryos. The outcomes from this project will help understand how dORFs are translated, shape gene expression and generate phenotypes. This novel function of the ribosome adds to the recently emerging regulatory effects of translation on gene expression (e.g. uORF, codon optimality). Understanding dORF biology will provide an entry point and perhaps even a diagnostic tool to associate mutations with human diseases. Identifying the molecular machinery involved in this pathway might provide targets for therapeutic interventions.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = $401,254 )
2025	2025	STOWERS INSTITUTE FOR MEDICAL RESEARCH	1000 E 50TH ST	KANSAS CITY	MO	64110	JACKSON	USA	Biomedical Research and Research Training	000	5	11/19/2024	NON-COMPETING CONTINUATION	$361,129
2025	2025	STOWERS INSTITUTE FOR MEDICAL RESEARCH	1000 E 50TH ST	KANSAS CITY	MO	64110	JACKSON	USA	Biomedical Research and Research Training	001	5	8/14/2025	NON-COMPETING CONTINUATION	$40,125
														Subtotal = $401,254

Issue Date FY: 2024 ( Subtotal = $401,254 )
2024	2024	STOWERS INSTITUTE FOR MEDICAL RESEARCH	1000 E 50TH ST	KANSAS CITY	MO	64110	JACKSON	USA	Biomedical Research and Research Training	001	4	6/25/2024	NON-COMPETING CONTINUATION	$40,125
2024	2024	STOWERS INSTITUTE FOR MEDICAL RESEARCH	1000 E 50TH ST	KANSAS CITY	MO	64110	JACKSON	USA	Biomedical Research and Research Training	000	4	11/2/2023	NON-COMPETING CONTINUATION	$361,129
														Subtotal = $401,254

Issue Date FY: 2023 ( Subtotal = $401,254 )
2023	2023	STOWERS INSTITUTE FOR MEDICAL RESEARCH	1000 E 50TH ST	KANSAS CITY	MO	64110	JACKSON	USA	Biomedical Research and Research Training	001	3	3/10/2023	NON-COMPETING CONTINUATION	$40,125
2023	2023	STOWERS INSTITUTE FOR MEDICAL RESEARCH	1000 E 50TH ST	KANSAS CITY	MO	64110	JACKSON	USA	Biomedical Research and Research Training	000	3	11/18/2022	NON-COMPETING CONTINUATION	$361,129
														Subtotal = $401,254

Issue Date FY: 2022 ( Subtotal = $401,254 )
2022	2022	STOWERS INSTITUTE FOR MEDICAL RESEARCH	1000 E 50TH	KANSAS CITY	MO	64110	JACKSON	USA	Biomedical Research and Research Training	000	2	12/3/2021	NON-COMPETING CONTINUATION	$361,128
2022	2022	STOWERS INSTITUTE FOR MEDICAL RESEARCH	1000 E 50TH ST	KANSAS CITY	MO	64110	JACKSON	USA	Biomedical Research and Research Training	001	2	7/28/2022	NON-COMPETING CONTINUATION	$40,126
														Subtotal = $401,254

Issue Date FY: 2021 ( Subtotal = $401,254 )
2021	2021	STOWERS INSTITUTE FOR MEDICAL RESEARCH	1000 E 50TH	KANSAS CITY	MO	64110	JACKSON	USA	Biomedical Research and Research Training	000	1	11/27/2020	NEW	$401,254
														Subtotal = $401,254

Grand Total All Awards = $2,006,270

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Small translated ORFs in the 3'UTR enhance translation in vertebrates

Award Number: R01GM136849

ORGANIZATION: NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 12/01/2020

PERIOD OF PERFORMANCE END DATE: 05/31/2026

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer